The New Drug Funding Program (NDFP) is administered by Cancer Care Ontario (CCO), and funds new and often very expensive cancer drugs, to ensure that Ontario patients have equal access to high-quality intravenous cancer drugs.

As the Government of Ontario’s cancer advisor, CCO's mandate is to reduce the number of people diagnosed with cancer and make sure patients get better care every step of the way.

The new solution will replace the existing NDFP operational database and provide program, policy, claims, and web content management for NDFP operations. The system will automate processes, streamline adjudication of claims, and improve turnaround times for reimbursement of cancer drug costs to hospitals.